This paper is in the following e-collection/theme issue:

Cancer Prognosis Models and Machine Learning (13) Decision Support for Health Professionals (1161) Clinical Information and Decision Making (1370) Innovations and Technology in Cancer Care (417)

Published on in Vol 7, No 2 (2021): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25800, first published .
Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Authors of this article:

Joseph Plasek1 Author Orcid Image ;   John Weissert1 Author Orcid Image ;   Tracy Downs2 Author Orcid Image ;   Kyle Richards2 Author Orcid Image ;   Kourosh Ravvaz1 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics

Joseph Plasek   1 , PhD ;   John Weissert   1 , BA ;   Tracy Downs   2 , MD ;   Kyle Richards   2 , MD ;   Kourosh Ravvaz   1 , PhD, MD, MPH

1 Advocate Aurora Research Institute, Milwaukee, WI, United States

2 School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States

Corresponding Author:

  • Kourosh Ravvaz, PhD, MD, MPH
  • Advocate Aurora Research Institute
  • 960 N 12th Street
  • Milwaukee, WI, 53233
  • United States
  • Phone: 1 4142195371
  • Fax: 1 4142195381
  • Email: ravvaz@gmail.com